ZA906898B - Screening methods for protease inhibitors - Google Patents

Screening methods for protease inhibitors

Info

Publication number
ZA906898B
ZA906898B ZA906898A ZA906898A ZA906898B ZA 906898 B ZA906898 B ZA 906898B ZA 906898 A ZA906898 A ZA 906898A ZA 906898 A ZA906898 A ZA 906898A ZA 906898 B ZA906898 B ZA 906898B
Authority
ZA
South Africa
Prior art keywords
protease inhibitors
screening methods
screening
methods
protease
Prior art date
Application number
ZA906898A
Other languages
English (en)
Inventor
Ellen Z Baum
Z Baum Ellen
Yakov Gluzman
Gluzman Yakov
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA906898B publication Critical patent/ZA906898B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA906898A 1989-09-11 1990-08-29 Screening methods for protease inhibitors ZA906898B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40560989A 1989-09-11 1989-09-11

Publications (1)

Publication Number Publication Date
ZA906898B true ZA906898B (en) 1991-06-26

Family

ID=23604414

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906898A ZA906898B (en) 1989-09-11 1990-08-29 Screening methods for protease inhibitors

Country Status (8)

Country Link
EP (1) EP0421109A3 (fr)
JP (1) JPH03164196A (fr)
KR (1) KR910006482A (fr)
AU (2) AU636383B2 (fr)
CA (1) CA2024277A1 (fr)
NZ (1) NZ235094A (fr)
PT (1) PT95213A (fr)
ZA (1) ZA906898B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013972A1 (fr) * 1991-02-11 1992-08-20 Thomas Jefferson University Bacteries produites par genie genetique afin d'identifier et de produire des agents medicalement importants
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
JPH07504654A (ja) * 1992-03-11 1995-05-25 ナルヘックス　リミテッド オキソ及びヒドロキシ置換炭化水素のアミン誘導体
MXPA93002392A (es) 1992-03-11 2005-02-04 Narhex Ltd Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
US5436131A (en) * 1993-04-02 1995-07-25 Merck & Co., Inc. Color screening assay for identifying inhibitor resistant HIV protease mutants
US5866351A (en) * 1993-07-07 1999-02-02 University Technology Corporation CD4+ T-lymphocyte proteases and genes encoding said proteases
US5413914A (en) * 1993-07-07 1995-05-09 The Regents Of The University Of Colorado Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases
US5691183A (en) * 1993-07-07 1997-11-25 University Technology Corporation CD4+ T-lymphoctye proteases and genes encoding said proteases
US5981259A (en) * 1993-07-07 1999-11-09 University Technology Corporation CD4+ T-lymphocyte protease genes and inhibitors thereof
US5861267A (en) * 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
US5948620A (en) * 1996-08-05 1999-09-07 Amersham International Plc Reverse two-hybrid system employing post-translation signal modulation
US6436666B1 (en) 1996-10-17 2002-08-20 Chiron Corporation Protease regulator screening assay
US6117639A (en) 1998-08-31 2000-09-12 Vertex Pharmaceuticals Incorporated Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity
FR2805544B1 (fr) * 2000-02-28 2004-07-16 Pasteur Institut Adenylcyclase recombinante et procede de tri de molecules a activite proteolytique utilisant cette adenylcyclase
JP4830079B2 (ja) * 2000-11-29 2011-12-07 国立感染症研究所長 プロテアーゼ活性の測定方法
WO2003012131A2 (fr) * 2001-07-27 2003-02-13 Ustav Organické Chemie A Biochemie Akademie Ved Ceské Republiky Dosages d'inhibiteurs de protease, procedes et moyens
EP2106899B1 (fr) 2008-04-04 2013-05-22 Dukane Corporation Presse ultrasonique utilisant un servomoteur et technique de mouvement différée
JP2011078436A (ja) * 2011-01-27 2011-04-21 National Institute Of Infectious Diseases プロテアーゼ活性の測定方法
WO2013006684A1 (fr) 2011-07-05 2013-01-10 The Gov. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health And Human Services. Essai de génotypage de vih-1 pour la surveillance globale d'une résistance à un médicament de vih-1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1254119A (fr) * 1984-07-20 1989-05-16 Lloyd A. Schick Methode de dosage d'un inhibiteur de protease
EP0321973B1 (fr) * 1987-12-23 1993-11-03 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Expression de la protéase P2A de HRV2 codée par un virus
DE3800233A1 (de) * 1988-01-07 1989-07-20 Hans Prof Dr Dr Wolf Methoden fuer die gentechnologische produktion einer rekombinanten, enzymatisch aktiven hiv spezifischen protease und der vorlaeufermolekuele der gruppenspezifischen antigene (gag) und der polymerase (pol) und verwendung dieser produkte in ansaetzen zur testung von hiv-protease spezifischen inhibitoren
DE3819846A1 (de) * 1988-06-10 1989-12-14 Hans Prof Dr Dr Wolf Testsystem fuer die entwicklung von inhibitoren der protease von hiv
US5073487A (en) * 1989-01-30 1991-12-17 Athens Research And Technology, Inc. Rapid assay for functional human α1 -proteinase inhibitor

Also Published As

Publication number Publication date
NZ235094A (en) 1991-09-25
PT95213A (pt) 1991-05-22
AU3392893A (en) 1993-05-20
EP0421109A2 (fr) 1991-04-10
AU636383B2 (en) 1993-04-29
CA2024277A1 (fr) 1991-03-12
EP0421109A3 (en) 1992-01-08
JPH03164196A (ja) 1991-07-16
KR910006482A (ko) 1991-04-29
AU6208490A (en) 1991-03-14

Similar Documents

Publication Publication Date Title
EP0410411A3 (en) Novel peptidase inhibitors
ZA906898B (en) Screening methods for protease inhibitors
EP0428849A3 (en) Retroviral protease inhibitors
GB8913090D0 (en) Method
HU906389D0 (en) New alpha-glycosidase inhibitors
EP0434663A3 (en) Dampingelement for skiboots
ZA907039B (en) Method for activating protein c
IL95380A0 (en) Peptidyl difluorodiol renin inhibitors
HU901879D0 (en) New alpha-glucosidase inhibitors
EP0427939A3 (en) Renin inhibitors
HUT60549A (en) Method for checking generqtors
GR900100777A (en) Improved method for useful diazinylpiperidines
GB8914748D0 (en) New method
GB9019728D0 (en) Method for improving cross-borehole surveys
IE893233L (en) Peptidase inhibitors
IE893229L (en) Peptidase inhibitors
IE892804L (en) Peptidase inhibitors
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
YU95388A (en) Process for obtaining new reninic inhibitors
EP0411144A4 (en) Profiling method
IE893446L (en) Serineprotease inhibitor proteins
IE894013L (en) Retroviral protease inhibitors
IE890075L (en) Renin inhibitors
IE891826L (en) Renin inhibitors
PL281172A1 (en) Method for manufacturingallyl isothiocyanate